Showing results (41-50 of 84) with videos related to
Sort By:
Pageof 9
Investigational New Drugs|April 10, 2023
Immunohistochemical analysis of B7-H3 expression in patients with lung cancer following various anti-cancer treatmentsShota Omori, Koji Muramatsu, Takuya Kawata, et al.Investigational New Drugs|September 21, 2020
Retrospective analysis of osimertinib re-challenge after osimertinib-induced interstitial lung disease in patients with EGFR-mutant non-small cell lung carcinomaHiroaki Kodama, Kazushige Wakuda, Michitoshi Yabe, et al.Japanese Journal of Clinical Oncology|October 13, 2021
Long-term outcomes in extensive disease small cell lung cancer patients treated without immune checkpoint inhibitorsKazushige Wakuda, Michitoshi Yabe, Hiroaki Kodama, et al.Thoracic Cancer|June 20, 2025
Effect of Cancer Cachexia on the Efficacy and Treatment Delivery of Chemotherapy in Older Patients With Advanced Small Cell Lung CancerMichitoshi Yabe, Tateaki Naito, Suguru Matsuda, et al.Cancer Medicine|September 29, 2021
Impact of angiogenesis inhibitor eligibility on the prognosis of patients with non-small cell lung cancer harboring EGFR mutationHiroaki Kodama, Hirotsugu Kenmotsu, Takanori Kawabata, et al.Cancer Medicine|December 10, 2020
Unfavorable impact of decreased muscle quality on the efficacy of immunotherapy for advanced non-small cell lung cancerNaoya Nishioka, Tateaki Naito, Akifumi Notsu, et al.Journal of Cancer Research and Clinical Oncology|September 17, 2021
Trophoblast cell-surface antigen 2 expression in lung cancer patients and the effects of anti-cancer treatmentsShota Omori, Koji Muramatsu, Takuya Kawata, et al.Clinical Lung Cancer|March 25, 2020
Association Between Clinical Tumor Burden and Efficacy of Immune Checkpoint Inhibitor Monotherapy for Advanced Non-Small-Cell Lung CancerTaichi Miyawaki, Hirotsugu Kenmotsu, Keita Mori, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 22, 2021
Impact of weight loss on treatment with PD-1/PD-L1 inhibitors plus chemotherapy in advanced non-small-cell lung cancerTaichi Miyawaki, Tateaki Naito, Michitoshi Yabe, et al.Cancer Chemotherapy and Pharmacology|April 30, 2017
The incidence and risk factors of febrile neutropenia in chemotherapy-naïve lung cancer patients receiving etoposide plus platinumTakumi Fujiwara, Hirotsugu Kenmotsu, Tateaki Naito, et al.Pageof 9